Table 1 Comparison of prevalence and frequency of major criteria in NBCCS patients among four studies.
From: Nevoid basal cell carcinoma syndrome (Gorlin syndrome)
| Â | Evans et al. [5] United Kingdom, 1993 | Shanley et al. [12] Australia, 1994 | Kimonis et al. [6] United States, 1997 | Lo Muzio et al. [11] Italy, 1999 | Ahn SG et al. [14] Korea, 2004 | Pruvost-Balland et al. [15] France, 2006 |
|---|---|---|---|---|---|---|
Patients | 84 | 118 | 105 | 37 | 33 | 22 |
Prevalence | 1/56,000 | 1/164,000 | NR | 1/256,000 | 1/13,939,393 | NR |
Major criteria % or (% African-Americans) | ||||||
BCCs | 47 | 76 | 80 (38) | 30 | 15.2 | 100 |
   Age > 20 y | 73 | 85 | 91 | 17 | - | - |
   Age > 40 y | 90 | 95 | 97 | 75 | - | - |
Jaw cyst | 66 | 75 | 74 | 92 | 90.9 | 62 |
Palm/plant pits | 71 | 80 | 87 | 35 | 66.7 | 45 |
Calcification of falx cerebri | NR | 92 | 65 | 70 | 21.2 | 66 |